title: Complement C2 deficiency disarranging innate and adaptive humoral immune responses in a pediatric patient: treatment with rituximab.
authors.affiliation: University Medical Center Carl-Gustav-Carus, Technical University, Dresden, Germany. fabian.hauck@inserm.fr
authors.forename: Fabian
authors.initials: F
authors.lastname: Hauck
authors.forename: Min Ae
authors.initials: MA
authors.lastname: Lee-kirsch
authors.forename: Daniela
authors.initials: D
authors.lastname: Aust
authors.forename: Joachim
authors.initials: J
authors.lastname: Roesler
authors.forename: Frank
authors.initials: F
authors.lastname: Pessler
mesh_terms: D056704:Adaptive Immunity / Q000187:drug effects*; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D001402:B-Lymphocytes / Q000187:drug effects / Q000276:immunology; D001706:Biopsy; D002675:Child, Preschool; D003175:Complement C2 / Q000172:deficiency*; D005260:Female; D006801:Humans; D056724:Immunity, Humoral / Q000187:drug effects*; D007113:Immunity, Innate / Q000187:drug effects*; D007150:Immunohistochemistry; D007153:Immunologic Deficiency Syndromes / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D007155:Immunologic Factors / Q000627:therapeutic use*; D008180:Lupus Erythematosus, Systemic / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D000069283:Rituximab; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D003175:Complement C2; D007155:Immunologic Factors; D000069283:Rituximab